Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2017-08-18
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Reward and Punishment on Goal-directed and Habit Learning in Adolescent Anorexia Nervosa
NCT04051879
Restrictive Eating Disorders: From Childhood Orality Disorder to Adolescent Dysensoriality
NCT05091983
Neuroscience-informed Treatment to Remotely Target Reward Mechanisms in Post-acute Anorexia Nervosa
NCT05799872
Meal-Based Exposure and Response Prevention in Anorexia Nervosa
NCT03747835
Mobile Application for Relapse Prevention in Eating Disorders Beliefs in Three Patients in Remission.
NCT06842862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recovered from anorexia nervosa
Those who have a past diagnosis of AN (defined by the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria) but are currently recovered, as shown by BMI over 18.5 throughout the last 12 months (self-report and current weight measured). Defined as either 'fully recovered'and: score must be within the 'normal range' of the Eating Disorders Examination Questionnaire (EDE-Q) global mean scores for young women, below 20 on the EAT-26 and below 16 on the Clinical Impairment Assessment for Eating Disorders (CIA); or partially recovered where one or more of these scores may be above the above-mentioned cutoffs.
Volatility task
Participants complete a volatility task, with pupillometry; and a Wisconsin Card Sort Task.
High scoring on the EAT-26
Those who score above 20 on the EAT-26, but who do not declare a former diagnosis of an eating disorder (though they may meet criteria for a current diagnosis during the Structured Clinical Interview for the DSM-5).
Volatility task
Participants complete a volatility task, with pupillometry; and a Wisconsin Card Sort Task.
Healthy controls
No history of or current diagnosis of any psychiatric disorder (especially eating disorders) which could impact study results.
Volatility task
Participants complete a volatility task, with pupillometry; and a Wisconsin Card Sort Task.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Volatility task
Participants complete a volatility task, with pupillometry; and a Wisconsin Card Sort Task.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females aged 18 to 45 years.
* BMI over 18.5 and has remained so for the last year.
* Participant is a fluent English speaker. Inclusion: recovered from anorexia
* Past formal diagnosis of AN (defined by DSM-5 criteria).
* Fully recovered: Score must be below 2.767 on the EDE-Q, below 16 on the CIA, and below 20 on the EAT-26 or partially recovered: scores may be above 2.767, 16 and 20 respectively.
Inclusion: high scoring on EAT-26
* Score above 20 on the EAT-26 questionnaire. Inclusion: healthy control
* Score below 2.767 on the EDE-Q, below 16 on the CIA, and below 20 on the EAT-26.
Exclusion Criteria
* Any current psychotropic medications.
* Current regular cigarette smoking of over 5 cigarettes per day.
* Recent use of illicit drugs.
* Alcohol intake which indicates an element of alcohol abuse; or unwillingness to refrain from drinking the night before the study visit.
Exclusion for high scoring EAT-26
• A former formal diagnosis of an eating disorder. Note that in this group a current diagnosis of EDNOS will not be an exclusion criterion.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip J Cowen, Prof
Role: PRINCIPAL_INVESTIGATOR
University of Oxford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, University of Oxford
Oxford, Oxfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R51898/RE003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.